Spink9 - serine peptidase inhibitor, Kazal type 9

Predicted to enable serine-type endopeptidase inhibitor activity. Predicted to be involved in negative regulation of endopeptidase activity. Predicted to act upstream of or within negative regulation of proteolysis. Orthologous to human SPINK9 (serine peptidase inhibitor Kazal type 9). [provided by Alliance of Genome Resources, Apr 2022]